The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESH MPN 2026 | Deciphering fibrotic niches using NicheSphere in MPNs: study insights and implications
Hélène Gleitz, PhD, Erasmus MC, Rotterdam, Netherlands, provides insights into a study deciphering fibrotic niches in myeloproliferative neoplasms (MPNs) using a double genetic fate-tracing approach and a bioinformatics pipeline to analyze how cells in the bone marrow interact to drive disease over time. Dr Gleitz highlights that this deeper understanding of early disease mechanisms may help to identify new therapeutic targets and therapies. This interview took place at the ESH 11th Translational Research Conference on Myeloproliferative Neoplasms (ESH MPN 2026) in Estoril, Portugal.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
